QA: Northwest Biotherapeutics INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001072379_2018_Northwest_Biotherapeutics_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001072379, Northwest Biotherapeutics INC

  xvar xval
0 AssetsCurrent 1,402,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 169,000
3 remainder_Assets 47,336,000
4 LiabilitiesCurrent 87,683,000
5 LiabilitiesNoncurrent 8,517,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,084,281
9 ResearchAndDevelopmentExpense 13,026,169
10 remainder_Expenses 15,837,087
11 remainder_Revenues 293,818
12 remainder_NetIncome -5,373,530
13 remainder_ComprehensiveNetIncome 1,968,200
  yvar yval
0 Assets 48,907,000
1 Liabilities 96,200,000
2 Expenses 40,947,537
3 Revenues 293,818
4 StockholdersEquity -47,293,000
5 NetIncome -46,027,249
6 ComprehensiveNetIncome -45,043,149
7 BaseVar 96,845,042
8 EconomicCapitalRatiobeforeLimitedLiability -2.04
9 EconomicCapitalRatio 1.01

Edgar->Model Mapping

Feature Distribution

Change over Time